Related Experiment Video
Updated: Jan 9, 2026

Optimization of the Cuff Technique for Murine Heart Transplantation
Published on: June 26, 2020
Increased mortality when combining older donors and recipients in heart transplantation
Martin Geard Walsh1, Ervin Y Cui2, Divyaam Satija1
1Department of Surgery, Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43201, United States.
Insights
Older donor hearts (over 55) are increasingly used in older recipients. This combination paradoxically increases mortality risk, though these organs remain vital given organ shortages.
Area of Science:
- Cardiology
- Transplant Surgery
- Gerontology
Background:
- The use of hearts from older donors is rising, especially for elderly recipients.
- The impact of older donor hearts on transplant outcomes across various recipient age groups requires further investigation.
Purpose of the Study:
- To assess the effect of older donor hearts on post-transplant survival rates in different recipient age categories.
- To analyze the utilization patterns of older donor hearts in relation to recipient age.
Main Methods:
- Utilized data from the Organ Procurement and Transplant Network (OPTN) database (2006-March 2024).
- Categorized transplants into four groups based on donor age (>55 years) and recipient age (>60 years).
- Employed Kaplan-Meier curves and Cox regression models for statistical analysis.
Main Results:
- Hearts from donors over 55 comprised 2.6% of all heart transplants.
- Older donor hearts were more frequently used in older recipients (4.0%) compared to younger recipients (1.8%).
- Old donor/old recipient and young donor/old recipient pairings showed increased post-transplant mortality risk, while old donor/young recipient did not. Older recipients experienced more significant survival differences with older donors compared to younger recipients.
Conclusions:
- Older donor hearts are preferentially used in older recipients, yet this combination is linked to higher mortality.
- Despite the increased risk, older donor hearts are valuable for all recipient age groups due to organ scarcity.
- Further research may explore strategies to mitigate risks associated with older donor-recipient pairings.
Background:
The utilization of hearts from older donors has increased, particularly for older recipients. However, the impact of older donor hearts on recipients of different ages is less known.
Aim:
To determine the impact of older donor hearts on post-transplant outcomes across different recipient age groups.
Methods:
The Organ Procurement and Transplant Network database was queried from 2006 to March 2024. Four groups were created stratifying by donor age (> 55 years) and recipient age (> 60 years). Kaplan-Meier curves and Cox regression models were used.
Results:
One thousand fifty out of 39868 transplants (2.6%) were performed utilizing hearts from older donors. The rate of older donor hearts in younger recipients was only 1.8%, while the older donor hearts were used 4.0% in older recipients (P < 0.001). Old donor/old recipient and young donor/old recipient combinations were associated with post-transplant mortality [hazard ratio (HR): 1.64 (95%CI: 1.42-1.90) and 1.42 (95%CI: 1.34-1.51)], while old donor/young recipient was not. Within each recipient age group, the older recipient groups showed greater differences in 1- and 5-year survival probabilities (80.4% and 67.4% with old donors, 89.2% and 76.8% with young donors) than younger recipient groups (90.3% and 77.5% with old donors, 92.2% and 80.3% with young donors).
Conclusion:
This study demonstrates the higher utilization of older donor hearts (aged more than 55) in older recipients. Paradoxically, the combination of older donor hearts with older recipients is associated with a higher risk of mortality. However, these organs remain valuable options across all recipient age groups in current context of organ shortage.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant II: Surgical Procedure

